What's Wrong With Merck's Stock?
Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S 500.
Why isn't Merck's stock doing better in 2024?
More importantly, could this healthcare company make for a good investment today?
Source Fool.com
Merck KGaA Stock
€168.35
-1.380%
Our community is currently high on Merck KGaA with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 172 € shows a slightly positive potential of 2.17% compared to the current price of 168.35 € for Merck KGaA.
